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INTRODUCTION
The tendency of patients and clinicians to overestimate inter-
vention benefits is an acknowledged contributor to healthcare
overuse.1,2 For many conditions, not actively intervening is a
legitimate option, such as for self-limiting conditions which
can resolve without intervention (other than for symptom
management), for conditions where ‘wait and watch’ is appro-
priate, or where not having a screen or test is reasonable. As
part of shared decision-making and campaigns such as Choos-
ing Wisely,3 patients are encouraged to ask ‘what happens if I
do nothing?’. To help patients construct informed preferences
and decisions congruent with their values, part of a decision
aid’s role can be to correct misperceptions about the benefits
and harms of intervention options, including not intervening.4
For conditions where not actively intervening is reasonable,
informed decision-making requires discussion about the con-
dition’s natural history, such as timeframes to recovery or
other likely consequences. We aimed to analyze the inclusion
and quantitative description of a ‘no active intervention’ op-
tion in all publicly available decision aids.
METHODS
We conducted an international environmental scan of decision
aids (with no language restriction), searching databases and
websites (Box 1) during October 2018. A decision aid was
defined as an evidence-based tool designed to help patients
make specific and deliberated choices among healthcare
options.5 To be eligible, the full aid needed to be freely
obtainable. Each aid’s content was analyzed independently
by two raters. Data extracted included health condition; deci-
sion under consideration; whether a ‘no active intervention’
option was presented (if so, the verbatim wording) and wheth-
er quantification of that option’s consequences (e.g. likelihood
of an outcome, timeframe of illness duration and/or recovery)
were provided. For aids without a ‘no active intervention’
option and/or quantitative description, discussion was held
between the three authors as to whether that was appropriate.
For aids without a ‘no active intervention’ option, we assessed
if the aid was a ‘focused’ aid (see Fig. 1) and therefore
reasonable to not include this option.
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Box 1. Sources Searched to Identify Patient Decision Aids
RESULTS
Of 519 unique decision aids identified, 48 were excluded (5
did not meet decision aid definition; 43 were not accessible),
leaving 471 eligible and included Broad decision types
addressed were treatment (331, 70%), preventive treatments
(except screening) (54, 11%), screening (defined as a test
conducted in people without disease signs or symptoms) (60,
13%), and diagnostic tests (26, 6%).
‘No Active Intervention’ Option. Just over half (270, 57%) of
the aids explicitly included a ‘no active intervention’ option (Fig.
1). Most (206, 76%) worded this as ‘do not do/have…[the active
option]’. Other ways used to describe this option were: ‘watchful
waiting’ (42, 16%); comparing a treatment to the placebo (aids
that were simply converted from a Cochrane review; 10, 4%);
self-management of symptoms (7, 3%); and ‘stop taking …[a
current treatment]’ (5, 2%).
Of the 201 (43%) aids that did not present a ‘no active
intervention’ option, this was appropriate for many (e.g. two
methods of childbirth delivery). However, 15 (3%) of the aids
could have, but did not, include a ‘no active intervention’
option (see Fig. 1 for examples).
Quantitative Description of the ‘No Active Intervention’
Option. Of the 270 aids that included a ‘no active
intervention’ option, 99 quantitatively described the
consequences of that option. We assessed that 77 decision
aids could have but did not; and for 94 aids, presenting this
information was not reasonable (see Fig. 1 for examples).
DISCUSSION
Deciding to not have or delay having a screen, test, or treat-
ment is sometimes appropriate. However, this option may be
underused unless it is discussed explicitly by clinicians and
patients. Unambiguous inclusion of this option in decision
aids is important for facilitating such discussions, along with
evidence-based estimates of likely timeframes or outcomes if
this option is chosen. Our finding that most decision aids
included a ‘no active intervention’ option when relevant is
reassuring for clinicians and patients. When the option and its
outcomes are not provided in aids, clinicians should incorpo-
rate this information into the discussion with patients. As it is a
criterion in the International Patient Decision Aid Standards,6
A to Z inventory of the Ottawa Patient Decision Aids Research Group at the Ottawa 
Health Research Institute (https://decisionaid.ohri.ca/AZinvent.php) The inventory 
contains decision aids that met a minimal set of criteria. 
Med-Decs - an international database for support in medical choices 
(https://www.med-decs.org/en). This European initiative aims to provide all Euro-
pean and worldwide patient decision aids related to medical treatments. 
Decision aids identified in the Cochrane review of patient decision aids (5)
Websites which contain collections of decision aids:  Harding Center for Risk Lit-
eracy (Germany); Patient als Partner (University Medical Center Hamburg-
Eppendorf); Mayo Clinic; University of Sydney decision aids; University of Laval 
decision boxes; Memorial Sloan-Kettering Cancer Center; UK National Institute for 
Health and Care Excellence; UK Patient.info; Institute for Quality and Efficiency in 
Healthcare (IQWiG, Germany); Weisse Liste (Germany); Home Doctor (Thuisarts, 
Netherlands); Consultation card (consultkaart, Netherlands); Patient +decision aid 
(Keuzehulp, Germany); AOK Gesundheits-kasse (Germany); Helsana (Switzer-
land); Techniker Krankenkasse (Germany)
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decision aid developers should ensure this information is
included. A possible limitation is that our search may not have
located decision aids not contained in any of the major sources
searched. Equipping clinicians with the knowledge and skills
to have a collaborative discussion with patients when they ask
‘what happens if I do nothing?’ is an important but largely
neglected aspect of informed decision-making.
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Figure 1 Decision aids grouped according to whether they included a ‘no active intervention’ option and quantitative description of it.
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